RxNorm Semantic Concepts Index - 295
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "295".
| RxCUI | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| RxCUI: 29501 | meningococcal group A polysaccharide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 29503 | meningococcal group C polysaccharide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 29508 | Menthone | Designated preferred name (PT) | NO | |
| RxCUI: 29508 | Menthone | Full form of descriptor (FN) | NO | |
| RxCUI: 29512 | Pecazine | Designated preferred name (PT) | NO | |
| RxCUI: 29512 | Pecazine | Full form of descriptor (FN) | NO | |
| RxCUI: 29512 | Pecazine | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 29517 | Mephenoxalone | Designated preferred name (PT) | NO | |
| RxCUI: 29517 | Mephenoxalone | Full form of descriptor (FN) | NO | |
| RxCUI: 29518 | mepindolol | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 295217 | temafloxacin hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |
| RxCUI: 29523 | meprednisone | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 29523 | meprednisone | Designated preferred name (PT) | NO | |
| RxCUI: 29523 | meprednisone | Full form of descriptor (FN) | NO | |
| RxCUI: 29523 | meprednisone | Designated preferred name (PT) | NO | |
| RxCUI: 29523 | meprednisone | Full form of descriptor (FN) | NO | |
| RxCUI: 29528 | mequitazine | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 29528 | mequitazine | Designated preferred name (PT) | NO | |
| RxCUI: 29528 | mequitazine | Full form of descriptor (FN) | NO | |
| RxCUI: 29528 | mequitazine | Designated preferred name (PT) | NO | |
| RxCUI: 29528 | mequitazine | Full form of descriptor (FN) | NO | |
| RxCUI: 29533 | Mercaptomerin | Designated preferred name (PT) | NO | |
| RxCUI: 29533 | Mercaptomerin | Full form of descriptor (FN) | NO | |
| RxCUI: 29542 | Ammoniated mercury | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 29542 | Ammoniated mercury | Designated preferred name (PT) | NO | |
| RxCUI: 29542 | Ammoniated mercury | Full form of descriptor (FN) | NO | |
| RxCUI: 29542 | Ammoniated mercury | Designated preferred name (PT) | NO | |
| RxCUI: 29542 | Ammoniated mercury | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 29542 | Ammoniated mercury | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 29542 | Ammoniated mercury | Full form of descriptor (FN) | NO | |
| RxCUI: 29545 | Yellow mercuric oxide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 29545 | Yellow mercuric oxide | Designated preferred name (PT) | NO | |
| RxCUI: 29545 | Yellow mercuric oxide | Full form of descriptor (FN) | NO | |
| RxCUI: 29545 | Yellow mercuric oxide | Designated preferred name (PT) | NO | |
| RxCUI: 29545 | Yellow mercuric oxide | Full form of descriptor (FN) | NO | |
| RxCUI: 29545 | Yellow mercuric oxide | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| RxCUI: 29547 | Mercury (II) reductase | Designated preferred name (PT) | NO | |
| RxCUI: 29547 | Mercury (II) reductase | Full form of descriptor (FN) | NO | |
| RxCUI: 2955 | curcumin | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 29561 | meropenem | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| RxCUI: 29561 | meropenem | Designated preferred name (PT) | YES | |
| RxCUI: 29561 | meropenem | Full form of descriptor (FN) | YES | |
| RxCUI: 29561 | meropenem | Designated preferred name (PT) | YES | |
| RxCUI: 29561 | meropenem | Full form of descriptor (FN) | YES | |
| RxCUI: 295717 | Rufloxacin hydrochloride | Designated preferred name (PT) | NO | |
| RxCUI: 295717 | Rufloxacin hydrochloride | Full form of descriptor (FN) | NO | |
| RxCUI: 29584 | mesulfen | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| RxCUI: 29590 | metaclazepam hydrochloride | Precise Ingredient (PIN) | A specified form of the ingredient that may or may not be clinically active. Most precise ingredients are salt or isomer forms. | NO |